Led by University of Cincinnati and Cincinnati Children’s researchers, new trial results published in The Lancet Psychiatry found the drug metformin can help manage weight gain in youth taking ...
The FDA has approved Caplyta as adjunctive therapy with antidepressants to treat major depressive disorder in adults, ...
NDA submission expected in early Q1 2026 for expanded usage of IGALMI® in home setting based on positive data from the ...
Starting medication for bipolar disorder isn’t easy — but practical tips from those who’ve been there can make the path a little smoother. Managing medication isn’t always easy — but small, consistent ...
The number of people suffering from depression or bipolar disorders in Korea has surged, with cases of each of the conditions ...
Clinical trials in human beings are in progress on using heart drugs for the treatment of bipolar disorder following its ...
AI-generated personalized bipolar management plans present growth opportunities driven by rising mental health awareness, ...
News Medical on MSN
BD² expands global effort to examine the key mechanisms of bipolar disorder
Today, BD², or Breakthrough Discoveries for thriving with Bipolar Disorder, announced its third round of Discovery Research grants, totaling nearly $18 million – expanding a comprehensive global ...
Lumateperone is approved as an adjunctive treatment for MDD, expanding its indications beyond schizophrenia and bipolar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback